Table 3.
Oral HPV genotype distribution by country in the HIM study oral subcohort
| Brazil (N = 1,198) n (%) | Mexico (N = 1,005) n (%) | USA (N =895) n (%) | p-value1 | |
|---|---|---|---|---|
| High-risk HPV types | ||||
| HPV 16 | 20 (1.7) | 18 (1.8) | 14 (1.6) | 0.93 | 
| HPV 18 | 8 (0.7) | 5 (0.5) | 2 (0.2) | 0.39 | 
| HPV 31 | 2 (0.2) | 4 (0.4) | 2 (0.2) | 0.61 | 
| HPV 33 | 1 (0.1) | 0 (0.0) | 4 (0.5) | 0.04 | 
| HPV 35 | 1 (0.1) | 3 (0.3) | 4 (0.5) | 0.23 | 
| HPV 39 | 3 (0.3) | 15 (1.5) | 4 (0.5) | <0.01 | 
| HPV 45 | 2 (0.2) | 5 (0.5) | 1 (0.1) | 0.26 | 
| HPV 51 | 9 (0.8) | 15 (1.5) | 7 (0.8) | 0.16 | 
| HPV 52 | 10 (0.8) | 5 (0.5) | 7 (0.8) | 0.61 | 
| HPV 56 | 10 (0.8) | 4 (0.4) | 3 (0.3) | 0.28 | 
| HPV 58 | 3 (0.3) | 3 (0.3) | 1 (0.1) | 0.80 | 
| HPV 59 | 2 (0.2) | 3 (0.3) | 2 (0.2) | 0.89 | 
| HPV 68 | 0 (0.0) | 1 (0.1) | 0 (0.0) | 0.61 | 
| Low-risk HPV types | ||||
| HPV 6 | 13 (1.1) | 13 (1.3) | 4 (0.5) | 0.15 | 
| HPV 11 | 2 (0.2) | 6 (0.6) | 0 (0.0) | 0.03 | 
| HPV 34 | 0 (0.0) | 0 (0.0) | 0 (0.0) | n/a | 
| HPV 40 | 0 (0.0) | 0 (0.0) | 0 (0.0) | n/a | 
| HPV 42 | 0 (0.0) | 0 (0.0) | 0 (0.0) | n/a | 
| HPV 43 | 0 (0.0) | 0 (0.0) | 1 (0.1) | 0.29 | 
| HPV 44 | 2 (0.2) | 2 (0.2) | 1 (0.1) | 1.00 | 
| HPV 53 | 9 (0.8) | 4 (0.4) | 6 (0.7) | 0.55 | 
| HPV 54 | 4 (0.3) | 0 (0.0) | 0 (0.0) | 0.04 | 
| HPV 66 | 13 (1.1) | 4 (0.4) | 10 (1.1) | 0.14 | 
| HPV 70 | 0 (0.0) | 1 (0.1) | 1 (0.1) | 0.53 | 
| HPV 74 | 9 (0.8) | 5 (0.5) | 6 (0.7) | 0.76 | 
p-values were corrected for multiple comparisons using Benjamini and Hochberg method.